IBDEI0MO ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10190,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10190,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,10190,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,10190,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,10191,0)
;;=E10.52^^39^430^31
;;^UTILITY(U,$J,358.3,10191,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10191,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,10191,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,10191,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,10192,0)
;;=E11.00^^39^431^19
;;^UTILITY(U,$J,358.3,10192,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10192,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
;;^UTILITY(U,$J,358.3,10192,1,4,0)
;;=4^E11.00
;;^UTILITY(U,$J,358.3,10192,2)
;;=^5002627
;;^UTILITY(U,$J,358.3,10193,0)
;;=E11.01^^39^431^18
;;^UTILITY(U,$J,358.3,10193,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10193,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
;;^UTILITY(U,$J,358.3,10193,1,4,0)
;;=4^E11.01
;;^UTILITY(U,$J,358.3,10193,2)
;;=^5002628
;;^UTILITY(U,$J,358.3,10194,0)
;;=E11.21^^39^431^7
;;^UTILITY(U,$J,358.3,10194,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10194,1,3,0)
;;=3^DM Type 2 w/ Diab Nephropathy
;;^UTILITY(U,$J,358.3,10194,1,4,0)
;;=4^E11.21
;;^UTILITY(U,$J,358.3,10194,2)
;;=^5002629
;;^UTILITY(U,$J,358.3,10195,0)
;;=E11.22^^39^431^3
;;^UTILITY(U,$J,358.3,10195,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10195,1,3,0)
;;=3^DM Type 2 w/ Diab CKD
;;^UTILITY(U,$J,358.3,10195,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,10195,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,10196,0)
;;=E11.39^^39^431^28
;;^UTILITY(U,$J,358.3,10196,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10196,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,10196,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,10196,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,10197,0)
;;=E11.41^^39^431^6
;;^UTILITY(U,$J,358.3,10197,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10197,1,3,0)
;;=3^DM Type 2 w/ Diab Mononeuropathy
;;^UTILITY(U,$J,358.3,10197,1,4,0)
;;=4^E11.41
;;^UTILITY(U,$J,358.3,10197,2)
;;=^5002645
;;^UTILITY(U,$J,358.3,10198,0)
;;=E11.42^^39^431^13
;;^UTILITY(U,$J,358.3,10198,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10198,1,3,0)
;;=3^DM Type 2 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,10198,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,10198,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,10199,0)
;;=E11.43^^39^431^2
;;^UTILITY(U,$J,358.3,10199,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10199,1,3,0)
;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,10199,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,10199,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,10200,0)
;;=E11.44^^39^431^1
;;^UTILITY(U,$J,358.3,10200,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10200,1,3,0)
;;=3^DM Type 2 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,10200,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,10200,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,10201,0)
;;=E11.49^^39^431^8
;;^UTILITY(U,$J,358.3,10201,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10201,1,3,0)
;;=3^DM Type 2 w/ Diab Neurological Compl
;;^UTILITY(U,$J,358.3,10201,1,4,0)
;;=4^E11.49
;;^UTILITY(U,$J,358.3,10201,2)
;;=^5002649
;;^UTILITY(U,$J,358.3,10202,0)
;;=E11.59^^39^431^25
;;^UTILITY(U,$J,358.3,10202,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0MO 3752 printed Nov 22, 2024@17:01:52 Page 2
IBDEI0MO ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10190,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,10190,1,3,0)
+4 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
+5 ;;^UTILITY(U,$J,358.3,10190,1,4,0)
+6 ;;=4^E10.51
+7 ;;^UTILITY(U,$J,358.3,10190,2)
+8 ;;=^5002610
+9 ;;^UTILITY(U,$J,358.3,10191,0)
+10 ;;=E10.52^^39^430^31
+11 ;;^UTILITY(U,$J,358.3,10191,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,10191,1,3,0)
+14 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
+15 ;;^UTILITY(U,$J,358.3,10191,1,4,0)
+16 ;;=4^E10.52
+17 ;;^UTILITY(U,$J,358.3,10191,2)
+18 ;;=^5002611
+19 ;;^UTILITY(U,$J,358.3,10192,0)
+20 ;;=E11.00^^39^431^19
+21 ;;^UTILITY(U,$J,358.3,10192,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,10192,1,3,0)
+24 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
+25 ;;^UTILITY(U,$J,358.3,10192,1,4,0)
+26 ;;=4^E11.00
+27 ;;^UTILITY(U,$J,358.3,10192,2)
+28 ;;=^5002627
+29 ;;^UTILITY(U,$J,358.3,10193,0)
+30 ;;=E11.01^^39^431^18
+31 ;;^UTILITY(U,$J,358.3,10193,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,10193,1,3,0)
+34 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
+35 ;;^UTILITY(U,$J,358.3,10193,1,4,0)
+36 ;;=4^E11.01
+37 ;;^UTILITY(U,$J,358.3,10193,2)
+38 ;;=^5002628
+39 ;;^UTILITY(U,$J,358.3,10194,0)
+40 ;;=E11.21^^39^431^7
+41 ;;^UTILITY(U,$J,358.3,10194,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,10194,1,3,0)
+44 ;;=3^DM Type 2 w/ Diab Nephropathy
+45 ;;^UTILITY(U,$J,358.3,10194,1,4,0)
+46 ;;=4^E11.21
+47 ;;^UTILITY(U,$J,358.3,10194,2)
+48 ;;=^5002629
+49 ;;^UTILITY(U,$J,358.3,10195,0)
+50 ;;=E11.22^^39^431^3
+51 ;;^UTILITY(U,$J,358.3,10195,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,10195,1,3,0)
+54 ;;=3^DM Type 2 w/ Diab CKD
+55 ;;^UTILITY(U,$J,358.3,10195,1,4,0)
+56 ;;=4^E11.22
+57 ;;^UTILITY(U,$J,358.3,10195,2)
+58 ;;=^5002630
+59 ;;^UTILITY(U,$J,358.3,10196,0)
+60 ;;=E11.39^^39^431^28
+61 ;;^UTILITY(U,$J,358.3,10196,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,10196,1,3,0)
+64 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
+65 ;;^UTILITY(U,$J,358.3,10196,1,4,0)
+66 ;;=4^E11.39
+67 ;;^UTILITY(U,$J,358.3,10196,2)
+68 ;;=^5002643
+69 ;;^UTILITY(U,$J,358.3,10197,0)
+70 ;;=E11.41^^39^431^6
+71 ;;^UTILITY(U,$J,358.3,10197,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,10197,1,3,0)
+74 ;;=3^DM Type 2 w/ Diab Mononeuropathy
+75 ;;^UTILITY(U,$J,358.3,10197,1,4,0)
+76 ;;=4^E11.41
+77 ;;^UTILITY(U,$J,358.3,10197,2)
+78 ;;=^5002645
+79 ;;^UTILITY(U,$J,358.3,10198,0)
+80 ;;=E11.42^^39^431^13
+81 ;;^UTILITY(U,$J,358.3,10198,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,10198,1,3,0)
+84 ;;=3^DM Type 2 w/ Diab Polyneuropathy
+85 ;;^UTILITY(U,$J,358.3,10198,1,4,0)
+86 ;;=4^E11.42
+87 ;;^UTILITY(U,$J,358.3,10198,2)
+88 ;;=^5002646
+89 ;;^UTILITY(U,$J,358.3,10199,0)
+90 ;;=E11.43^^39^431^2
+91 ;;^UTILITY(U,$J,358.3,10199,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,10199,1,3,0)
+94 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
+95 ;;^UTILITY(U,$J,358.3,10199,1,4,0)
+96 ;;=4^E11.43
+97 ;;^UTILITY(U,$J,358.3,10199,2)
+98 ;;=^5002647
+99 ;;^UTILITY(U,$J,358.3,10200,0)
+100 ;;=E11.44^^39^431^1
+101 ;;^UTILITY(U,$J,358.3,10200,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,10200,1,3,0)
+104 ;;=3^DM Type 2 w/ Diab Amyotrophy
+105 ;;^UTILITY(U,$J,358.3,10200,1,4,0)
+106 ;;=4^E11.44
+107 ;;^UTILITY(U,$J,358.3,10200,2)
+108 ;;=^5002648
+109 ;;^UTILITY(U,$J,358.3,10201,0)
+110 ;;=E11.49^^39^431^8
+111 ;;^UTILITY(U,$J,358.3,10201,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,10201,1,3,0)
+114 ;;=3^DM Type 2 w/ Diab Neurological Compl
+115 ;;^UTILITY(U,$J,358.3,10201,1,4,0)
+116 ;;=4^E11.49
+117 ;;^UTILITY(U,$J,358.3,10201,2)
+118 ;;=^5002649
+119 ;;^UTILITY(U,$J,358.3,10202,0)
+120 ;;=E11.59^^39^431^25
+121 ;;^UTILITY(U,$J,358.3,10202,1,0)
+122 ;;=^358.31IA^4^2
